Latest 13D/G Reports

Since Nov 12, 2025

Company Symbol Filer Shares owned Ownership %
Republic Digital Acquisition Co RDAG METEORA CAPITAL, LLC 2.35M 7.84%
DESTINATION XL GROUP, INC. DXLG Nantahala Capital Management, LLC 4.51M 8.36%
COMPASS Pathways plc CMPS Nantahala Capital Management, LLC 3.48M 3.57%
VISTAGEN THERAPEUTICS, INC. VTGN Nantahala Capital Management, LLC 3.19M 9.99%
Eupraxia Pharmaceuticals Inc. EPRX DISBROW ROBERT 3.57M 7%
ETSY, INC. ETSY Holocene Advisors, LP 3.11M 3.13%
908 Devices Inc. MASS First Light Asset Management, LLC 3.56M 9.84%
UNICYCIVE THERAPEUTICS, INC. UNCY Nantahala Capital Management, LLC 1.86M 9.99%
Anteris Technologies Global Corp. AVR Nantahala Capital Management, LLC 1.92M 5.32%
Youxin Technology Ltd YAAS L1 Capital Global Opportunities Master Fund, Ltd. 67.3K 1.6%
Theratechnologies Inc. THTX Nantahala Capital Management, LLC 0 0%
TRISALUS LIFE SCIENCES, INC. TLSI Nantahala Capital Management, LLC 2.04M 4.09%
ALTISOURCE PORTFOLIO SOLUTIONS S.A. ASPS Nantahala Capital Management, LLC 1.01M 8.39%
THIRD HARMONIC BIO, INC. THRD Nantahala Capital Management, LLC 0 0%
Tyra Biosciences, Inc. TYRA Commodore Capital LP 3.38M 6.3%
Axogen, Inc. AXGN First Light Asset Management, LLC 5.94M 12.88%
Funko, Inc. FNKO COOPER CREEK PARTNERS MANAGEMENT LLC 0 0%
Cogent Biosciences, Inc. COGT Paradigm Biocapital Advisors LP 3.16M 2.3%
Agios Pharmaceuticals, Inc. AGIO Paradigm Biocapital Advisors LP 2.87M 4.9%
1 800 FLOWERS COM INC FLWS Nantahala Capital Management, LLC 3.37M 9.21%
Cidara Therapeutics, Inc. CDTX Paradigm Biocapital Advisors LP 961K 3.3%
WORK Medical Technology Group LTD WOK L1 Capital Global Opportunities Master Fund, Ltd. 0 0%
Savara Inc. SVRA Nantahala Capital Management, LLC 8.78M 5.08%
RAPT Therapeutics, Inc. RAPT Nantahala Capital Management, LLC 623K 3.77%
SOS Ltd SOS L1 Capital Global Opportunities Master Fund, Ltd. 1.88M 0.2%
Rain Enhancement Technologies Holdco, Inc. RAIN METEORA CAPITAL, LLC 429K 5.7%
LENZ Therapeutics, Inc. LENZ Paradigm Biocapital Advisors LP 1.07M 3.8%
Warby Parker Inc. WRBY Durable Capital Partners LP 8.75M 8.3%
Quince Therapeutics, Inc. QNCX Nantahala Capital Management, LLC 5.62M 9.99%
Merus N.V. MRUS Paradigm Biocapital Advisors LP 4.67M 6.2%
UroGen Pharma Ltd. URGN Paradigm Biocapital Advisors LP 4.22M 9%
Cohen Circle Acquisition Corp. I CCIR SONA ASSET MANAGEMENT (US) LLC 0 0%
NEKTAR THERAPEUTICS NKTR Nantahala Capital Management, LLC 419K 2.2%
Teucrium Commodity Trust CORN HIGHLAND GLOBAL ALLOCATION FUND 0 0%
Y-mAbs Therapeutics, Inc. YMAB Paradigm Biocapital Advisors LP 0 0%
KIORA PHARMACEUTICALS, INC. KPRX Nantahala Capital Management, LLC 364K 9.99%
InspireMD, Inc. NSPR Nantahala Capital Partners Limited Partnership 2.42M 5.68%
Sonim Technologies, Inc. SONM L1 Capital Global Opportunities Master Fund, Ltd. 0 0%
Evommune, Inc. LSP 7 Cooperative UA 4.93M 15.7%
XCel Brands, Inc. XELB Potomac Capital Management, Inc. 409K 8.6%
Shift4 Payments, Inc. FOUR Durable Capital Partners LP 5.63M 8.4%
CLARITEV CORPORATION CTEV Hellman & Friedman Investors VIII, L.P. 3.89M 23.5%
MILLICOM INTERNATIONAL CELLULAR SA TIGO Atlas Investissement SAS 70.5M 42.2%
Relay Therapeutics, Inc. RLAY Commodore Capital LP 17M 9.9%
Delek US Holdings, Inc DK Ion Asset Management Ltd. 1.85M 3.07%
INSMED Inc INSM Darwin Global Management, Ltd. 20.5M 9.7%
SONIM TECHNOLOGIES INC SONM 1 MAIN CAPITAL MANAGEMENT, LLC 1.52M 8.2%
Lemonade, Inc. LMND SoftBank Group Capital Ltd 3.56M 4.8%
Full Truck Alliance Co. Ltd. YMM SB INVESTMENT ADVISERS (UK) LTD 1.39B 7.4%
Coupang, Inc. CPNG SB INVESTMENT ADVISERS (UK) LTD 290M 17.3%
Roivant Sciences Ltd. ROIV SB INVESTMENT ADVISERS (UK) LTD 40.3M 5.8%
JOYY Inc. JOYY STONEHILL CAPITAL MANAGEMENT LLC 27.6M 2.7%
Fractyl Health, Inc. GUTS MAVERICK CAPITAL LTD 4.25M 3.1%
Oculis Holding AG OCS Pivotal bioVenture Partners Fund I, L.P. 2.82M 4.9%
Pharvaris N.V. PHVS Bain Capital Life Sciences Fund, L.P. 1.87M 3%
Curis, Inc. CRIS MAVERICK CAPITAL LTD 49.6K 0.4%
DIANTHUS THERAPEUTICS, INC. DNTH BCLS Fund III Investments, LP 1.32M 3.1%
Pacific Gas & Electric Company PCGPRA STONEHILL CAPITAL MANAGEMENT LLC 817K 7.9%
UNITY BIOTECHNOLOGY, INC. UNBX ARCH Venture Fund VII, L.P. 0 0%
Sana Biotechnology, Inc. SANA ARCH Venture Fund IX, L.P. 46.1M 17.3%
Lyell Immunopharma, Inc. LYEL ARCH Venture Fund IX, L.P. 2.76M 13%
Peabody Energy Corporation BTU MAVERICK CAPITAL LTD 8.16M 6.7%
Scilex Holding Co SCLX ORAMED PHARMACEUTICALS INC. 833K 9.9%
CIDARA THERAPEUTICS, INC. CDTX BCLS Fund III Investments, LP 3.02M 9.99%
WaterBridge Infrastructure LLC WBI WBR Holdings LLC 62.1M 60.9%
Jefferson Capital, Inc. JCAP JCF IV JCAP Holding L.P. 43.7M 75%
Adagene Inc. ADAG Panacea Innovation Ltd 2.25M 3.8%
BRP Inc. DOOO Bain Capital Integral Investors II, L.P. 10.5M 23.2%
Genius Sports Limited GENI Locke Mark 17.1M 7.2%
Heartflow, Inc. HTFL BCLS Fund III Investments, LP 12.4M 14.9%
Viper Energy Inc. VNOM Blackstone Holdings III L.P. 9.73M 5.5%
StubHub Holdings, Inc. STUB Baker Eric Howard 32.7M 9.4%
CENTURY THERAPEUTICS, INC. IPSC Bain Capital Life Sciences Opportunities III, LP 3.54M 4.1%
O-I Glass, Inc. /DE/ OI COOPER CREEK PARTNERS MANAGEMENT LLC 10.1M 65%
Trevi Therapeutics, Inc. TRVI Frazier Life Sciences Public Fund, L.P. 8.51M 7%
JADE BIOSCIENCES, INC. JBIO Frazier Life Sciences Public Fund, L.P. 1.38M 4.2%
Scienture Holdings, Inc. SCNX L1 Capital Global Opportunities Master Fund, Ltd. 0 0%
Willow Tree Capital Corp HERSHEY TRUST CO TRUSTEE IN TRUST FOR MILTON HERSHEY SCHOOL 2.23M 10.9%
Outset Medical, Inc. OM Durable Capital Partners LP 1.37M 7.6%
Coatue Innovative Strategies Fund LAFFONT PHILIPPE 7.33M 3.51%
Savara Inc SVRA Growth Equity Opportunities 17, LLC 24.5M 12%
Context Therapeutics Inc. CNTX Avidity Partners Management LP 9.2M 9.9%
Evolent Health, Inc. EVH Durable Capital Partners LP 0 0%
Verona Pharma plc VRNA Pentwater Capital Management LP 0 0%
Upstream Bio, Inc. UPB TCG Crossover GP I, LLC 2.12M 3.9%
Palmer Square Capital BDC Inc PSBD First Trust Capital Management L.P. 1.29M 4.04%
Clear Secure, Inc. YOU Durable Capital Partners LP 6.37M 6.7%
Zymeworks Inc. ZYME BIOTECHNOLOGY VALUE FUND L P 3.94M 5.2%
AMC ENTERTAINMENT HOLDINGS, INC. AMC Pentwater Capital Management LP 48.6M 9.5%
Cogent Biosciences, Inc. COGT TCG Crossover GP I, LLC 6.8M 4.8%
CBIZ, Inc. CBZ Durable Capital Partners LP 3.93M 7.3%
Core Scientific, Inc./tx CORZ Pentwater Capital Management LP 26.1M 8.5%
Immatics N.V. IMTX BAKER BROS. ADVISORS LP 12.1M 9.95%
Globa Terra Acquisition Corp GTERA Globa Terra Management LLC 4.72M 20.2%
Canterbury Park Holding Corp CPHC Black Diamond Capital Management I, LLLP 859K 16.8%
Rithm Acquisition Corp. RAC METEORA CAPITAL, LLC 1.71M 7.21%
ETHZilla Corp STEADFAST CAPITAL MANAGEMENT LP 7.18M 4.5%
89bio, Inc. ETNB Pentwater Capital Management LP 0 0%
SAB Biotherapeutics, Inc. SABS BIOTECHNOLOGY VALUE FUND L P 5.17M 9.99%
Cerus Corporation CERS BAKER BROS. ADVISORS LP 10M 5.2%